Literature DB >> 2522269

Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty.

P W Serruys1, H Suryapranata, F Piscione, E Harmsen, M van den Brand, P de Feyter, P G Hugenholtz, J W de Jong.   

Abstract

The response of myocardial lactate and hypoxanthine metabolism during percutaneous transluminal coronary angioplasty was studied in a series of 15 patients undergoing this procedure. A minimum of 4 balloon inflations was performed per patient with an average duration per occlusion of 49 +/- 11 seconds (mean +/- standard deviation) for a total occlusion time of 192 +/- 40 seconds. Thermodilution coronary venous blood flow measured in the great cardiac vein decreased from control values of 72 +/- 4 ml/min (mean +/- standard error of the mean) to 47 +/- 10 ml/min with the fourth coronary occlusion (p less than 0.005). Arteriovenous lactate and hypoxanthine showed peak differences during the reactive hyperemia after the first 2 occlusions which did not increase after subsequent occlusions. Within minutes after the procedure, lactate and hypoxanthine efflux was no longer seen, demonstrating the reversibility of the metabolic disturbances after repeated ischemia. The results of this study indicate that there is no permanent alteration in lactate or hypoxanthine metabolism after percutaneous transluminal coronary angioplasty with 4 coronary occlusions of 40 to 60 seconds' duration, with a total occlusion time of 192 +/- 40 seconds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522269     DOI: 10.1016/0002-9149(89)90230-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Effect of gallopamil on myocardial ischaemia during percutaneous transluminal coronary angioplasty.

Authors:  B Rauch; J Neumann; G Richardt; R Kranzhöfer; R Barth; R Zimmermann; H P Koch; H Tillmanns; A Schömig
Journal:  Drugs       Date:  1991       Impact factor: 9.546

2.  Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris.

Authors:  K Ogino; S Osaki; N Noguchi; H Kitamura; H Omodani; M Kato; I Hisatome; T Matsumoto; T Kinugawa; H Miyakoda
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease.

Authors:  J W de Jong; J J Bonnier; T Huizer; R Ciampricotti; J R Roelandt
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.